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Introduction
During adipogenesis, the unique structural, biochemical, and 
endocrine properties that define mature adipocytes are estab-
lished through a complex and highly orchestrated gene expression 
program. Chronological expression of adipose-specific genes is 
achieved by sequential activation of a network of regulatory fac-
tors. To date, numerous factors have been identified that partici-
pate in the positive or negative control of adipogenesis. The vast 
majority of these factors are involved in transcriptional regulation 
(1). Peroxisome proliferator–activated receptor γ (PPARγ) is the 
master transcriptional regulator of adipocyte differentiation and 
is necessary and sufficient for the development of adipocytes (2, 
3). Many genes in mature adipocytes are direct transcriptional tar-
gets of PPARγ (4–6). Other important proadipogenic transcription 
factors include members of the CCAAT/enhancer-binding protein 
(C/EBP) family, the Krüppel-like factor (KLF) family, and early B 
cell factors 1 and 2 (EBF1 and EBF2) (7–9). A number of factors 
that negatively regulate adipogenesis have also been identified, 
including the Wnt pathway, GATA factors, and preadipocyte fac-
tor 1 (PREF-1) (10–12). Transcriptional cofactors, such as PPARγ 
coactivator-1α (PGC1α), PR domain–containing 16 (PRDM16), 
and transducin-like enhancer of split 3 (TLE3), have been found 
to interact with key transcription factors, fine-tune the adipogenic 
program, and/or specify white versus brown adipocyte fate (13–15).
The contribution of posttranscriptional factors to the estab-
lishment of the adipocyte phenotype is less well understood. 
Several microRNAs have been reported to positively or negative-
ly affect the abundance of adipogenic RNAs through a posttran-
scriptional mechanism, including miR-27 and let-7 (16, 17). The 
pre-mRNA splicing regulator SAM68 was found to inhibit adipo-
genesis by controlling mTOR alternative splicing (18). Recently, 
the long noncoding RNA termed brown fat lncRNA 1 (BLNC1) 
was reported to indirectly influence the transcriptional activity 
of EBF2 (19). Nevertheless, in contrast with the well-established 
transcriptional cascade of adipogenesis, the mechanisms involved 
in orchestration of adipocyte development on the posttranscrip-
tional level have been largely unexplored.
Paraspeckles are subnuclear bodies located in the interchro-
matin space. These protein-RNA complexes are composed of the 
long noncoding RNA nuclear paraspeckle assembly transport 
1 (NEAT1) and 3 core protein components from the Drosophila 
behavior/human splicing (DBHS) family: paraspeckle component 
1 (PSPC1), non–POU domain–containing octamer-binding protein 
(NONO), and splicing factor proline- and glutamine-rich (SFPQ) 
(20). Before the identification of paraspeckles, NONO and SFPQ 
were implicated in various aspects of RNA production and pro-
cessing (21–25). Comparatively little is known about the cellular 
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the expression of other paraspeckle components was altered during 
differentiation. Sfpq and Nono were modestly induced during dif-
ferentiation in at least 1 cell line, and expression of Neat1 was mark-
edly increased in both (Supplemental Figure 1C), in agreement 
with a recent report (32). We also investigated whether PSPC1 
level was altered in obesity. We found that ob/ob mice expressed 
less Pspc1 mRNA in white adipose tissue (WAT) compared with WT 
controls (Figure 1C). We also observed reduced expression of Pspc1 
in WAT from mice fed a high-fat diet (Figure 1C and Supplemental 
Figure 1D). Interestingly, the expression pattern of PSPC1 in these 
models resembled that of PPARγ and adiponectin (Figure 1C). 
Examination of Pspc1 mRNA tissue distribution revealed promi-
nent expression in metabolically active tissues including WAT and 
brown adipose tissue (BAT) (Supplemental Figure 1E).
PSPC1 promotes adipogenesis in vitro. To elucidate the role of 
PSPC1 in adipogenesis, we overexpressed PSPC1 in 10T1/2 pread-
ipocytes via retroviral transduction (Figure 1D and ref. 3). We 
obtained stable cell lines derived from large populations of clones. 
These lines were then induced to differentiate for 7–8 days with the 
with the 1 μM dexamethasone, 0.5 mM IBMX, and 5 μg/ml insulin 
(DMI) plus 20 nM GW1929 (GW) cocktail. Expression of PSPC1 
increased the capacity of 10T1/2 cells to differentiate, as judged 
by Oil Red O staining (Figure 1E). Real-time PCR analysis during 
the differentiation time course confirmed increased expression 
of adipocyte-selective genes in cells overexpressing PSPC1 (Fig-
ure 1F and Supplemental Figure 1F). Comparable results were 
obtained in 3T3-L1 cells (Supplemental Figure 2, A and B).
As a complement to these gain-of-function studies, we 
expressed PSPC1 and PPARγ in combination (Supplemental Fig-
ure 2C). NIH-3T3 fibroblasts lack endogenous PPARγ expression 
and are therefore unable to differentiate into adipocytes. Consis-
tent with earlier work, introduction of PPARγ conferred the ability 
to differentiate, as shown by the induction of adipocyte genes (3). 
Expression of PSPC1 alone had little, if any, effect, whereas coex-
pression of PSPC1 and PPARγ resulted in a synergistic effect.
In order to assess the requirement for endogenous PSPC1 
expression during adipocyte differentiation, we generated ret-
roviruses encoding shRNA sequences against Pspc1. Knockdown 
of Pspc1 expression in 10T1/2 stable cell lines was confirmed by 
immunoblotting (Figure 1G). Morphological differentiation, as 
assessed by Oil Red O staining, was impaired in cells with reduced 
PSPC1 expression (Figure 1H). Reduced expression of PSPC1 was 
functions of PSPC1, although it has been suggested to be import-
ant for spermatogenesis (26, 27). Whether and how PSPC1 may 
play a role in RNA processing is unknown.
In the present study, we identify PSPC1 as an adipogenic factor 
through a phenotype-based high-throughput cDNA screen (14, 28). 
We further show that PSPC1 is a bona fide RNA-binding protein that 
shuttles from the nucleus to the cytoplasm during adipocyte differ-
entiation. PSPC1 directly interacts with adipocyte RNAs and pro-
motes their export, ultimately leading to increased protein expres-
sion. Loss of PSPC1 compromises adipogenesis and adipocyte gene 
expression both in vitro and in vivo, and affects the development of 
diet-induced obesity and insulin resistance. These studies shed light 
on the importance of PSPC1-dependent RNA maturation in adipo-
genesis and expand our knowledge of posttranscriptional processes 
contributing to adipocyte development and adipose function.
Results
PSPC1 is a direct target of PPARγ and is induced during adipogene-
sis. We previously performed a high-throughput screen for cDNAs 
affecting adipocyte differentiation (28). This screen identified 
TLE3 as a transcriptional modulator of adipogenic gene expres-
sion (14, 29). Another “hit” in this screen was the cDNA encoding 
the paraspeckle component PSPC1, which had not been previous-
ly linked with adipogenesis. To begin to address a potential func-
tion for PSPC1 in adipocytes, we first examined PSPC1 expres-
sion during the differentiation time course of 10T1/2 and 3T3-L1 
preadipocytes. Pspc1 mRNA expression rose during differentiation 
in both cell lines (Figure 1A), and PSPC1 protein expression was 
even more prominently increased (Figure 1B).
We next examined whether the Pspc1 gene was a direct target of 
PPARγ. To address whether PPARγ bound directly to the Pspc1 pro-
moter, we analyzed genome-wide ChIP sequencing data from 3T3-L1 
cells (30). We identified peaks for PPARγ and its heterodimeric part-
ner RXRα –0.2 kb from the transcription start site in the Pspc1 promot-
er (Supplemental Figure 1A; supplemental material available online 
with this article; doi:10.1172/JCI89484DS1), and sequence analysis 
identified a DR-1 sequence associated with this region (AGGTCAAG-
GGTTA). Directed ChIP–quantitative PCR assays confirmed that this 
–0.2-kb region was bound by PPARγ in a differentiation-dependent 
manner in 3T3-L1 cells (Supplemental Figure 1B).
PSPC1 has previously been reported to form a complex with 
other paraspeckle components (31). We therefore tested whether 
Figure 1. PSPC1 expression promotes adipogenesis. (A) Real-time PCR analysis of Pspc1 mRNA during the differentiation of 10T1/2 and 3T3-L1 preadi-
pocytes. Cells were stimulated to differentiate with dexamethasone (1 μM), IBMX (0.5 mM), insulin (5 μg/ml), and GW1929 (20 nM) for 2 days followed 
by insulin and GW1929 for 5 days. Comparison was made against D0 by 1-way ANOVA. Results represent 4 independent experiments. Unless mentioned 
otherwise, mRNA expression in this and all subsequent figures was normalized to 36B4 control. (B) Immunoblot analysis of PSPC1 protein during dif-
ferentiation of 10T1/2 and 3T3-L1 preadipocytes. Cells were treated as in A. Results are representative of 3 independent experiments. (C) Real-time PCR 
analysis of Pspc1, Pparg, and adiponectin mRNA in epididymal white adipose tissue from control ob/ob mice and WT C57BL/6 mice fed a high-fat diet 
(HFD) for 12 weeks. n = 8–10 per group. Statistical analysis was performed using Student’s t test. (D) Immunoblot analysis of PSPC1 protein expression in 
retrovirally derived 10T1/2 stable cell lines expressing vector or PSPC1. (E) Oil Red O staining of 10T1/2 stable cells described in D. Cells were stimulated to 
differentiate with DMI + 20 nM GW for 8 days. (F) Real-time PCR analysis of adipogenic gene expression in 10T1/2 stable cells described in D on differ-
ent days during differentiation. Cells were stimulated to differentiate as in E. Comparison was made against vector control by Student’s t test. Results 
represent 3 independent experiments. (G) Immunoblot analysis of PSPC1 protein expression in retrovirally derived 10T1/2 stable cell lines expressing PSPC1 
shRNAs (shPspc1, sh#1, and sh#2) or lacZ shRNA (shLacZ) control. (H) Oil Red O staining of the 10T1/2 stable cells described in G. Cells were stimulated 
to differentiate with DMI + 20 nM GW for 7 days. (I) Real-time PCR analysis of adipogenic gene expression in 10T1/2 stable cells described in G on different 
days during differentiation. Cells were stimulated to differentiate as in H. Comparison was made against shLacZ control by 1-way ANOVA. Results are 
representative of 3 independent experiments. Error bars represent mean + SEM. *P < 0.05, **P < 0.01.
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Figure 2. iCLIP-Seq identifies PSPC1 binding 
sites in adipocyte transcripts. (A) Immunoblot 
analysis of PSPC1 and PPARγ in retrovirally 
derived 10T1/2 stable cell lines expressing WT 
PSPC1 or an RRM point mutant (RNP Mut). 
Quantification of PSPC1 bands normalized to 
HMG1 bands is indicated. (B) Real-time PCR 
analysis of gene expression in 10T1/2 stable 
cells described in A. Cells were stimulated to 
differentiate with DMI + 20 nM GW for 7 days. 
Comparison was made against vector control by 
1-way ANOVA. Results represent 3 independent 
experiments. (C) Autoradiograph of cross-linked 
PSPC1-RNA complexes using denaturing gel 
electrophoresis. PSPC1-RNA complexes were 
immunopurified from 10T1/2 cells expressing 
vector or Flag-tagged PSPC1 (Fl-Pspc1) using 
Flag antibody. RNA was partially or fully digest-
ed using different concentrations of MNase. 
Complexes extending 20–40 kDa upward from 
the size of PSPC1 (59 kDa) were excised for 
further analysis (area indicated in squares).  
(D and E) PSPC1 iCLIP-Seq clusters mapped to 
the mouse EBF1 and ACSL1 gene (University of 
California, Santa Cruz, Genome Browser track). 
Four tracks in green, blue, yellow, and red repre-
sent day 0 vector, day 0 Fl-Pspc1, day 6 vector, 
and day 6 Fl-Pspc1, respectively. Peaks are piles 
of 30-nt significant clusters (cross-linking site ± 
15 nt). Height of the peaks indicates the number 
of clusters identified within the region. Results 
are representative of 2 independent iCLIP-Seq 
experiments. Error bars represent mean + SEM. 
*P < 0.05, **P < 0.01.
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samples recovered from the gel. We obtained 3.6 million and 3.0 
million nonredundant reads from PSPC1-bound RNA on differ-
entiation day 0 and day 6, respectively (Supplemental Table 1). 
We confirmed the quality of the reads (Supplemental Figure 4A) 
and analyzed their length distribution (Supplemental Figure 4B). 
Using the TopHat mapping tool, 1,024,730 (day 0) and 894,301 
(day 6) reads were uniquely aligned to the mouse (NCBI37/mm9) 
genome (Supplemental Table 1) (38). We next used the CLIP-Seq 
cluster-finding algorithm CLIPper to identify 25,743 (day 0) and 
38,084 (day 6) significant clusters (P < 0.05) (Supplemental Table 
1) (39). We further analyzed the genomic distribution of PSPC1 
binding sites. The majority of the binding sites (97% on day 0 and 
93% on day 6) were located within intronic regions, indicating that 
PSPC1 preferentially interacts with pre-mRNA in the nucleus. A 
minority of clusters was identified within 3′-UTRs (Supplemen-
tal Figure 4C). Interestingly, we observed a 2.5-fold increase in 
3′-UTR binding on day 6, suggesting a possible shift in preference 
or subcellular localization of the PSPC1-RNA interaction upon 
differentiation (Supplemental Figure 4C). Furthermore, de novo 
motif search with the HOMER algorithm identified AU-rich ele-
ments, UAAUU and UAUAU, within PSPC1-bound RNA sequenc-
es (Supplemental Figure 4D) (40). These analyses (library 1) were 
validated by a second library set (library 2) from an independent-
ly performed iCLIP-Seq experiment, reflected by approximately 
70% overlap in their target transcripts (Supplemental Figure 4E).
Pspc1 binds and regulates mRNA transcripts of adipocyte-selective 
genes. Next, we analyzed the target mRNAs of PSPC1 based on the 
CLIP-defined binding sites (Supplemental Table 2). We identified 
several candidate PSPC1-interacting transcripts that were previ-
ously known to play important roles in adipogenesis, including 
Ebf1, Pparg, Acsl1, and Scd1 (Figure 2, D and E, and Supplemental 
Figure 5). Neat1, a known binding partner of PSPC1, was one of 
the RNAs with the highest read number, confirming the validity 
of the assay (Supplemental Table 2). Scanning through a 15-Mb 
region flanking Ebf1 on the chromosome revealed very few PSPC1 
binding peaks, suggesting that our iCLIP approach had identified 
sequence-specific interactions (Supplemental Figure 5A).
To further validate the PSPC1-RNA interactions revealed 
by the iCLIP analysis, we immunoprecipitated either Fl-Pspc1 
(Figure 3, A and B) or endogenous PSPC1 (Figure 3, C and D) 
from 10T1/2 cells and measured transcript levels by real-time 
PCR. Immunoprecipitated transcript levels were normalized to 
levels of corresponding input RNA to control for differences in 
transcript abundance. These studies confirmed that both native 
and tagged PSPC1 interacts selectively with a panel of adipocyte 
RNAs identified in the iCLIP analysis. Importantly, we failed 
to detect robust interaction of PSPC1 with several abundantly 
expressed differentiation-dependent adipocyte transcripts that 
did not appear in our iCLIP results, including Lxra, Cebpa, Fasn, 
and adiponectin (Figure 3B).
We next addressed whether binding of adipogenic transcripts 
by PSPC1 had functional consequences. We hypothesized that 
modulating the amount of PSPC1 in the cell might affect target 
mRNA or protein expression. To verify whether PSPC1 promotes 
expression of its binding targets during differentiation, we exam-
ined RNA and protein levels of these targets in differentiated 
10T1/2 adipocytes on day 7. Stable expression of untagged PSPC1 
also associated with reduced expression of adipocyte genes (Fig-
ure 1I). Importantly, 2 different shRNA sequences targeting PSPC1 
impaired adipogenesis, and the degree of knockdown correlated 
with the effect on adipocyte gene expression. We observed similar 
effects in 3T3-L1 preadipocytes engineered to stably express these 
shRNA sequences (Supplemental Figure 2, D and E).
We also evaluated whether NONO and SFPQ were capable 
of promoting adipogenesis. While ectopic expression of PSPC1 
markedly increased differentiation, expression of either NONO or 
SFPQ alone had no effect (Supplemental Figure 2F). This finding 
suggests that either the adipogenic activity of PSPC1 is paraspeck-
le-independent or only PSPC1 levels are limiting during preadipo-
cyte differentiation.
The adipogenic capacity of Pspc1 depends on RNA binding. Next, 
we addressed the mechanism of PSPC1 action in adipogenesis. 
All three DBHS members, PSPC1, NONO, and SFPQ, contain 2 
tandem RNA recognition motifs (RRMs) that exhibit more than 
50% sequence identity (33). RRMs typically engage in sequence- 
specific recognition of short RNA motifs (34). We investigated 
whether the 2 RRMs were required for PSPC1 to drive adipogene-
sis. We generated stable cell lines that expressed a PSPC1 protein 
with point mutations within the 8–amino acid RNP consensus 
sequence in each of its RRM domains (RNP mutant, Figure 2A), 
or with deletions of either RRM1 or RRM2 (Supplemental Figure 
3A). Remarkably, while PSPC1 promoted adipocyte differentia-
tion, none of the RRM mutants promoted differentiation (Figure 
2B and Supplemental Figure 3B). Although the RRM1 and RRM2 
deletion mutants were expressed at slightly reduced levels com-
pared with WT (Supplemental Figure 3A), they completely lacked 
adipogenic activity. Immunoblotting for PPARγ in these differen-
tiated stable cells further confirmed an almost complete loss of 
PSPC1 adipogenic function when the RRMs were mutated (Figure 
2A). Together these data suggest that the 2 RRMs of PSPC1 are 
required for its adipogenic capacity.
RRM domains bind RNA with sequence-specificity. Inter-
estingly, prior studies have shown that the presence of a second 
RRM in a protein confers additional affinity and specificity for 
RNA recognition (34, 35). We therefore postulated that PSPC1 
might drive adipogenesis through interacting with mRNA tran-
scripts of differentiation-relevant genes. To test this idea, we used 
individual-nucleotide resolution cross-linking and immunopre-
cipitation (iCLIP) coupled with high-throughput sequencing to 
explore whether PSPC1 binds RNA, and if so, which species (36, 
37). We used 10T1/2 stable cells expressing vector or Flag-tagged 
PSPC1 (Fl-Pspc1). Cells before (day 0) and after (day 6) differen-
tiation were subjected to UV cross-linking and lysed, and then 
protein-RNA complexes were immunoprecipitated with Flag anti-
body. Purified PSPC1-bound RNAs were enzymatically fragment-
ed and radioactively labeled. When this purified PSPC1-RNA com-
plex was resolved by SDS-PAGE, we detected a radioactive signal 
at the exact molecular weight of Fl-Pspc1 with full RNA digestion, 
and shifted above the size of Fl-Pspc1 as a smear with partial RNA 
digestion (Figure 2C). Radioactive signal was undetectable in the 
vector control pull-down samples. These data strongly suggest 
that PSPC1 binds to RNA directly.
To identify genome-wide RNA targets of PSPC1, we per-
formed high-throughput sequencing on the PSPC1-bound RNA 
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(Psp), N-terminal Flag-tagged PSPC1 (Fl-Pspc1), or C-terminal 
Flag-tagged PSPC1 (Pspc1-Fl) all conferred increased levels of tar-
get mRNAs and proteins (Figure 4, A and B, and Supplemental Fig-
ure 6A). By contrast, point mutations in the 2 RRM domains abol-
ished the effects. Furthermore, stable expression of native PSPC1 
but not the RRM deletion mutants resulted in elevated expression 
levels of both target proteins and mRNAs on day 6 (Supplemental 
Figure 6, B and C).
To discriminate between direct and indirect — or between 
transcriptional and posttranscriptional — effects, we assessed 
the effects of PSPC1 in undifferentiated 10T1/2 preadipocytes to 
eliminate secondary effects due to differentiation. Remarkably, 
while native PSPC1 expression did not affect target mRNA lev-
els (Figure 4C), target protein levels were increased (Figure 4D 
and Supplemental Figure 6D), suggesting a posttranscriptional 
mechanism. This effect was not observed with the RRM deletion 
mutants. Although the RRM deletion mutants were expressed at 
slightly reduced levels compared with WT, they completely lacked 
activity, suggesting that the RRM domains are likely to contribute 
to these effects. Conversely, loss of endogenous PSPC1 strongly 
reduced protein levels of PSPC1 targets, with only minimal or no 
effect on mRNA expression (Figure 4, E and F, and Supplemental 
Figure 6E). Since these effects of PSPC1 expression and knock-
down were observed in the absence of differentiation, they were 
likely to be primary effects of PSPC1 modulation.
Pspc1 interacts with DDX3X in a differentiation- and RNA- 
dependent manner. RNA-binding proteins tend to form complexes 
that work cooperatively on the target RNA molecule. Paraspeck-
le complexes have not heretofore been studied in adipocytes, 
and therefore their composition in this cell type is unknown. 
Figure 3. PSPC1 selectively interacts with certain adipocyte RNAs. (A) Immunoblot analysis of Flag-tagged PSPC1 protein (Fl-Pspc1) in the whole cell 
lysate and immunopurified products. Differentiated 10T1/2 adipocytes stably expressing Fl-Pspc1 or vector were used. Following UV cross-linking, 3X Flag 
antibody was used for IP. (B) Real-time PCR analysis of target transcript levels in Flag-immunoprecipitated samples. RNA was isolated from input and 
IP samples described in A. Values represent the amount of each transcript in the IP sample normalized to its amount in the input sample. Neat1 serves 
as a positive control; cyclophilin and 36B4 serve as negative controls. Results are representative of 2 independent experiments. (C) Immunoblot analysis 
of endogenous PSPC1 protein in the whole cell lysate and immunopurified products. 10T1/2 adipocytes on differentiation day 6 were used. Following UV 
cross-linking, endogenous PSPC1 antibody and IgG isotype control antibody were used for IP. (D) Real-time PCR analysis of target transcript levels in the 
PSPC1-immunoprecipitated sample. RNA was isolated from input and IP samples described in C. Values represent the amount of each transcript in the 
IP sample normalized to its amount in the input sample. Neat1 serves as a positive control; cyclophilin and 36B4 serve as negative controls. Results are 
representative of 2 independent experiments. Error bars represent mean + SEM.
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We hypothesized that determining the PSPC1 protein interac-
tome in adipocytes might provide insight into the mechanism by 
which PSPC1-RNA binding regulates gene expression. We used 
coimmunoprecipitation (co-IP) coupled with mass spectrometry 
to investigate the constituents of PSPC1 complexes in preadipo-
cytes and adipocytes. We analyzed 10T1/2 stable cell lines that 
expressed Fl-Pspc1 at 2 differentiation time points (days 0 and 
7). Silver staining of the immunoprecipitated proteins revealed a 
number of bands that were enriched in the Fl-Pspc1 sample on day 
7 (Figure 5A, arrows). Mass spectrometry analysis of the immuno-
precipitated proteins generated a list of putative PSPC1 binding 
partners. To eliminate nonspecific binding, the list of candidates 
was compared with the sample from cells lacking Fl-Pspc1. Impor-
tantly, the 2 known PSPC1 interaction partners, NONO and SFPQ, 
had the highest confidence scores, confirming the validity of our 
approach. Among the other top interaction candidates, the major-
ity were known RNA-binding proteins, reinforcing the idea that 
PSPC1 is involved in RNA biology. Notably, the 2 categories with 
the highest number of interaction candidates were “RNA trans-
port” and “protein synthesis” (Supplemental Table 3).
We verified the interaction of candidates from our list using 
co-IP studies (Figure 5B and data not shown). One interacting pro-
tein, DEAD-box RNA helicase 3 (DDX3X), was of particular interest. 
First, it ranked alongside the known direct interactors, NONO and 
SFPQ; second, it was associated with PSPC1 in a differentiation-de-
pendent manner (Figure 5B). The finding that PSPC1-DDX3X asso-
Figure 4. PSPC1 influences the expression of iCLIP-identified target RNAs. (A) Real-time PCR analysis of target gene mRNA expression in differentiated 
10T1/2 cells stably expressing vector (Vect), N-terminal Flag-tagged PSPC1 (Fl-Pspc1), C-terminal Flag-tagged PSPC1 (Pspc1-Fl), untagged PSPC1 (Psp), or 
PSPC1 RNP mutant (RNP). Cells were stimulated to differentiate with DMI + 20 nM GW for 7 days. Comparison was made against vector control by 1-way 
ANOVA. Results represent 3 independent experiments. (B) Immunoblot analysis of target gene protein expression in differentiated 10T1/2 stable cell lines 
described in A. Results are representative of 3 independent experiments. (C) Real-time PCR analysis of target gene mRNA expression in undifferentiat-
ed 10T1/2 cells expressing vector (Vect), V5-tagged WT PSPC1 (Psp-V5), V5-tagged RRM1 deletion mutant (RRM1), or V5-tagged RRM2 deletion mutant 
(RRM2). Comparison was made against vector control by 1-way ANOVA. Results represent 3 independent experiments. (D) Immunoblot analysis of target 
gene protein expression in undifferentiated 10T1/2 cells described in C. Results are representative of 3 independent experiments. The immunoblots 
presented in D include replicate samples run on a parallel gel. (E) Real-time PCR analysis of target gene mRNA expression in undifferentiated 10T1/2 cells 
expressing PSPC1 shRNAs (shPspc1#1 and shPspc1#3) or lacZ shRNA control (shLacZ). Comparison was made against shlacZ control by 1-way ANOVA. 
Results represent 3 independent experiments. (F) Immunoblot analysis of target gene protein expression in undifferentiated 10T1/2 cells described in E. 
Results are representative of 3 independent experiments. Error bars represent mean + SEM. *P < 0.05, **P < 0.01.
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selectively required for interaction of PSPC1 with NONO, while 
both RRMs were required for interaction with DDX3X (Figure 5D).
Pspc1 translocates from nucleus to cytoplasm upon adipocyte 
differentiation. DDX3X is an ATP-dependent RNA helicase that 
participates in various aspects of mRNA metabolism, including 
mRNA nuclear export (42–44). Prior studies have shown that 
DDX3X interacts with mRNA ribonucleoprotein complexes in the 
nucleus and is exported along with the ribonucleoproteins to the 
cytoplasm (45–47). We therefore speculated that PSPC1, in a com-
ciation was induced by differentiation suggested it could have func-
tional relevance to adipogenesis. Since both PSPC1 and DDX3X are 
RNA-binding proteins (41), we examined whether their interaction 
was RNA-dependent. Treatment with RNase prior to IP of PSPC1 
abolished the PSPC1-DDX3X interaction, indicating that it was 
indeed RNA-dependent (Figure 5C). To determine whether the 
RNA-interacting RRMs were required for interaction with various 
PSPC1 complex components in adipocytes, we performed IPs with 
WT and RRM mutant PSPC1 proteins. We found that RRM2 was 
Figure 5. PSPC1 interacts with DDX3X and translocates from nucleus to cytoplasm during differentiation. (A) Silver staining of Flag-tagged PSPC1 
(Fl-Pspc1) coimmunoprecipitated proteins on a gradient Bis-Tris gel. Co-IP with Flag antibody was performed in 10T1/2 cells stably expressing Fl-Pspc1 or 
vector. Arrows indicate bands present exclusively in the Fl-Pspc1 lane. (B) Immunoblot analysis of proteins coimmunoprecipitated with Fl-Pspc1 in 10T1/2 
cells on differentiation day 0 and day 6. Cells were stimulated to differentiate with DMI + 20 nM GW. The known interaction partner NONO served as a pos-
itive control. Results are representative of 3 independent experiments. (C) Immunoblot analysis of DDX3X coimmunoprecipitated with Fl-Pspc1 in 10T1/2 
cells on differentiation day 6 (middle panel). Cell lysates were treated with control or RNase prior to IP (right panel). Results are representative of 2 inde-
pendent experiments. (D) Immunoblot analysis of DDX3X and NONO co-IP with PSPC1 and RRM mutants (ΔRRM1 and ΔRRM2). 10T1/2 stable cells were 
stimulated to differentiate with DMI + 20 nM GW. Results are representative of 2 independent experiments. (E) Immunoblot analysis of PSPC1 and NONO 
in the nuclear (Nuc) and cytoplasmic (Cyto) fractions of 10T1/2 cells on differentiation days 0 and 7. Cells were stimulated to differentiate with DMI + 20 
nM GW. HMG1 and α-tubulin served as nuclear and cytoplasmic markers, respectively. Results are representative of 3 independent experiments. (F) PSPC1 
subcellular localization visualized by fluorescent confocal microscopy in undifferentiated (Pre) and differentiated (Ad) 10T1/2 adipocytes stably express-
ing V5-tagged PSPC1 (Psp-V5). Cells were stimulated to differentiate with DMI + 20 nM GW for 7 days. Scale bars: 20 μm. Results are representative of 2 
independent experiments. (G) PSPC1 subcellular localization visualized by fluorescent confocal microscopy in undifferentiated (Pre) and differentiated (Ad) 
10T1/2 adipocytes stably expressing untagged PSPC1. Antibody against PSPC1 (red) was used for detecting endogenous PSPC1. Scale bars: 5 μm. Results 
are representative of 3 independent experiments.
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despite previous reports that PSPC1 was a constitutively nuclear 
protein, we detected a substantial fraction of PSPC1 protein in the 
cytoplasmic fraction on day 7 (Figure 5E). This finding suggested 
that PSPC1 might accompany its target mRNA transcripts from 
the nucleus into the cytoplasm during differentiation.
plex with DDX3X, might be exported out of the nucleus (together 
with its target mRNA) during adipogenesis. To test this hypothe-
sis, we performed nuclear-cytoplasmic fractionation on undiffer-
entiated and differentiated adipocytes. Before differentiation (day 
0), PSPC1 was present solely in the nuclear fraction. Surprisingly, 
Figure 6. PSPC1 facilitates nucleocyto-
plasmic export of target mRNAs. (A) 
Real-time PCR analysis of PSPC1 target 
transcripts at multiple time points 
following actinomycin D treatment 
in differentiated 10T1/2 cells stably 
expressing vector (Vect), Flag-tagged 
PSPC1 (Fl-Pspc1), or untagged PSPC1 
(Psp). Results represent 3 independent 
experiments. (B) Real-time PCR analysis 
of PSPC1 target transcripts at multiple 
time points following actinomycin D 
treatment in differentiated 10T1/2 cells 
stably expressing PSPC1 shRNA (shP-
spc1) or lacZ shRNA (shLacZ). Results 
represent 2 independent experiments. 
(C) Real-time PCR analysis of PSPC1 
target transcripts in the nuclear and 
cytoplasmic fractions of 10T1/2 cells 
expressing vector (Vect), Fl-Pspc1, or Psp. 
Values represent the cytoplasmic-to- 
nuclear ratio of each transcript. Lxrb 
served as a negative control. Compari-
son was made against vector control by 
1-way ANOVA. Results represent 3 inde-
pendent experiments. (D) Real-time PCR 
analysis of gene expression in control 
or PSPC1-transduced 10T1/2 cells trans-
fected with nontargeting siRNA control 
(siNC) or siRNA directed against Ddx3x 
(siDdx3x). Comparison was made against 
siNC control by Student’s t test. Results 
represent 2 independent experiments. 
(E) Immunoblot analysis of protein 
extracts from control or PSPC1-trans-
duced 10T1/2 cells transfected with 
nontargeting siRNA control (siNC) or 
siRNA directed against Ddx3x (siDdx3x). 
Results are representative of 2 indepen-
dent experiments. Error bars represent 
mean + SEM. *P < 0.05, **P < 0.01.
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cate that PSPC1 shuttles from the nucleus to the cytoplasm 
during adipocyte differentiation.
Pspc1 promotes nuclear export of adipogenic mRNAs. The 
discovery of PSPC1 translocation suggested that PSPC1 might 
facilitate adipocyte differentiation through a mechanism(s) 
affecting mRNA processing, transport, or stability. We initially 
tested whether PSPC1 enhanced target mRNA stability in the 
cytoplasm. We treated 10T1/2 adipocytes with actinomycin D 
to inhibit transcription and analyzed target transcript levels. 
We were unable to detect any alteration in rates of target mRNA 
degradation in cells with either increased or decreased PSPC1 
To provide additional evidence for PSPC1 translocation, 
we used confocal immunofluorescence microscopy to visu-
alize PSPC1 localization in preadipocytes and adipocytes. In 
preadipocytes, PSPC1 expression entirely colocalized with 
DAPI staining, consistent with nuclear localization. However, 
in mature adipocytes, there was a remarkable shift of PSPC1 
staining into the cytoplasm, consistent with results of our 
cell fractionation studies (Figure 5, F and G). In particular, 
the lipid-laden cells displayed prominent cytoplasmic PSPC1 
localization. Parallel studies were carried out with both epi-
tope-tagged and endogenous PSPC1 protein. These data indi-
Figure 7. PSPC1 is important for adipocyte differentiation and maintenance in vivo. (A) Weight of the fat pad formed from subcutaneous transplanta-
tion of 3T3-F442A preadipocytes expressing lacZ shRNA (shLacZ) or PSPC1 shRNA (shPspc1). Mice were sacrificed 4 weeks after transplantation. Six-week 
old male NCr nude mice were used, n = 4 per group. Statistical analysis was performed using Student’s t test. (B) Histological analysis of the fat pad 
formed from subcutaneous preadipocyte transplantation described in A. Scale bars: 100 μm. (C) Real-time PCR analysis of Pspc1 and adipose-specific 
genes in the fat pads formed from the subcutaneous preadipocyte transplantations described in A. Comparison was made against shCtrl by Student’s 
t test. (D) Immunoblot analysis of PSPC1 and PPARγ protein expression in the inguinal WAT of each Pspc1fl/fl mouse injected with GFP adenovirus in 1 
inguinal fat pad and Cre adenovirus in the contralateral pad. Mice were sacrificed 7 days after adenovirus injection. Eight-week-old male Pspc1fl/fl mice were 
used, n = 5. Results from 3 representative mice are shown. (E) Quantification of band intensity in D. Values represent intensity of PSPC1 or PPARγ2 bands 
normalized to intensity of corresponding HMG1 bands. Means of 3 representative mice are presented. (F) Real-time PCR analysis of adipose-specific genes 
in the inguinal WAT injected with adenovirus as described in D. Results from 3 representative mice are shown. Results are representative of 2 independent 
cohorts of mice. Error bars represent mean + SEM. *P < 0.05, **P < 0.01.
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we found that expression of the putative mRNA export factor 
DDX3X, with which PSPC1 interacts (Figure 5), was important for 
PSPC1 effects on its target protein expression. We knocked down 
DDX3X expression with siRNA in preadipocytes expressing ret-
roviral vector alone or PSPC1. Even partial loss of DDX3X protein 
led to a reduction in protein levels of EBF1, SCD-1, ASCL1, and 
PPARγ, without affecting levels of their corresponding mRNAs and 
without affecting levels of PSPC1 protein (Figure 6, D and E, and 
Supplemental Figure 7, B and C). This effect was most evident in 
cells overexpressing PSPC1 (Figure 6E, right), consistent with the 
hypothesis that DDX3X facilitates the action of PSPC1.
Pspc1 is required for adipogenesis in vivo. Finally, we tested the 
importance of PSPC1 for adipocyte differentiation and main-
tenance in vivo. To address whether PSPC1 activity contributes 
to adipocyte development, we assessed the capacity of PSPC1 
(Figure 6, A and B), suggesting that PSPC1 does not stabilize 
these transcripts.
We next addressed whether PSPC1 was able to facilitate mRNA 
export from the nucleus. We performed nuclear-cytoplasmic frac-
tionation (Supplemental Figure 7A) and analyzed PSPC1-interact-
ing RNAs in each fraction. Adipocytes stably expressing native or 
Flag-tagged PSPC1 exhibited an elevated cytoplasmic-to-nuclear 
ratio of a number of mRNA targets compared with control cells, 
including Ebf1, Pparg, Acsl1, Scd1, and Cd36 (Figure 6C). Impor-
tantly, this finding did not appear to reflect a general effect on all 
mRNAs, as those not found to interact with PSPC1, such as Lxrb, 
were not different between control and PSPC1-expressing cells. 
These observations suggest that PSPC1 facilitates adipocyte differ-
entiation by promoting the nuclear export of a subset of mRNAs, 
resulting in augmented protein expression. In support of this idea, 
Figure 8. Adipose-specific PSPC1-deficient mice are resistant to diet-induced obesity. (A) Body weight of Pspc1fl/fl (F/F) and Pspc1fl/fl Cre+ (KO) mice fed 
chow diet for 10 weeks and then switched to 60% HFD. n = 8 per group, female mice. Statistical analysis was performed using Student’s t test. (B) External 
appearance of representative F/F and KO mice shown in A at 20 weeks of age after 10 weeks on HFD. (C) Body fat and lean mass in F/F and KO mice at 8 
weeks old on chow diet and at 20 weeks old after 10 weeks on HFD determined by EchoMRI. n = 8 per group, female mice. Comparison was made against 
F/F control mice by Student’s t test. (D) Average weight of individual white and brown adipose fat pads from F/F and KO mice after 10 weeks on HFD. n 
= 8 per group, 20-week-old female mice. Comparison was made against F/F control mice by Student’s t test. (E) Representative F/F and KO mice after 
10 weeks on HFD showing grossly reduced adipose tissue content in the absence of PSPC1. (F) Gross appearance of tissues from F/F and KO mice after 10 
weeks on HFD. (G) Histology of tissues from F/F and KO mice after 10 weeks on HFD. Results are representative of 2 independent cohorts of mice. Scale 
bars: iWAT and epididymal white adipose tissue (eWAT), 100 μm; BAT and liver, 50 μm. Error bars represent mean + SEM. *P < 0.05, **P < 0.01.
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sition after 10 weeks on a high-fat diet confirmed reduced body 
fat in adipose PSPC1–deficient mice with no change in body lean 
mass (Figure 8C). On visual inspection after laparotomy, adipose 
PSPC1–deficient mice had much less adipose tissue, and the size 
and weight of individual fat pads were correspondingly reduced 
(Figure 8, D–F). The size of white adipocytes in both the inguinal 
white adipose tissue (iWAT) and the epididymal white adipose tis-
sue (eWAT) depots was smaller in adipose PSPC1–deficient mice 
(Figure 8G). Both the BAT and the liver of adipose PSPC1–deficient 
mice showed histological evidence of rescued lipid accumulation 
compared with controls (Figure 8G). Spleen and liver size was not 
different between groups (Figure 8F). Plasma triglyceride and cho-
lesterol levels were also not different (Supplemental Figure 9B).
We next asked whether adipose-specific Pspc1 deletion might 
result in altered systemic energy balance. Surprisingly, metabolic 
cage analysis revealed a dramatic elevation in VO2, VCO2, and 
energy expenditure rate (EE) in mice lacking adipose PSPC1 com-
pared with floxed controls (Figure 9, A–C, and Supplemental Figure 
9C). Further analysis of the EE data using analysis of covariance 
(ANCOVA) with body mass or lean mass as covariant confirmed 
an increase in EE in adipose PSPC1–deficient mice compared with 
controls (Supplemental Figure 9D). Food intake was not different 
between genotypes (Figure 9D). Activity was slightly increased in 
adipose PSPC1–deficient mice (Supplemental Figure 9E).
We went on to explore whether loss of adipose PSPC1 expres-
sion affected systemic metabolism in the setting of a high-fat diet 
challenge. Mice lacking PSPC1 in adipose tissue fed with a high-
fat diet had improved glucose tolerance compared with controls 
(Figure 9E). Furthermore, insulin tolerance tests revealed an 
improved response to exogenous insulin in PSPC1-deficient mice, 
suggesting that loss of PSPC1 expression ameliorates the develop-
ment of high-fat diet–induced insulin resistance (Figure 9F).
Consistent with the finding that PSPC1 expression affects adi-
pocyte gene expression, we found reduced expression of multiple 
adipocyte genes in iWAT from adipose PSPC1–deficient mice (Fig-
ure 9G). Interestingly, there was increased expression of genes 
linked to beiging in iWAT and increased expression of thermogenic 
genes in BAT in PSPC1-deficient mice compared with controls (Fig-
ure 9H). This finding is unlikely to reflect direct antagonistic actions 
of PSPC1 on thermogenic genes, as overexpression of PSPC1 pro-
moted brown adipocyte differentiation in vitro (Supplemental Fig-
ure 9F). Furthermore, despite the fact that Pspc1 deletion was spe-
cific for adipose tissue, we also found elevated expression of genes 
involved in fatty acid utilization, including that encoding acyl-CoA 
oxidase, in the skeletal muscle of adipose PSPC1–deficient mice 
knockdown preadipocytes to form fat pads when transplanted into 
immunocompromised mice. We used 3T3-F442A cells for these 
studies, as they efficiently form fat pads (48). Four weeks after 
subcutaneous transplantation, preadipocytes transduced with 
PSPC1 shRNA (shPspc1) gave rise to markedly smaller fat pads 
compared with controls. The average fat pad weight was lower, 
suggesting that fewer adipocytes were derived from PSPC1 knock-
down preadipocytes compared with controls (Figure 7A). Histo-
logical analysis of the control fat pads revealed primarily mature 
adipocytes with large unilocular lipid droplets, resembling WAT. 
By contrast, fat pads from the shPspc1 group contained more stro-
mal tissue and relatively few adipocytes, suggesting that cells with 
decreased PSPC1 expression had impaired differentiation capaci-
ty in vivo (Figure 7B). Gene expression analysis also revealed low-
er levels of adipocyte mRNAs in the shPspc1 fat pads (Figure 7C). 
Comparable results were obtained for multiple shRNA constructs 
in multiple independent experiments (Supplemental Figure 8A).
As a complementary approach to address PSPC1 function in 
vivo, we generated Pspc1-floxed mice (Pspc1fl/fl) (Supplemental Figure 
8, B and C) and used Cre-expressing adenovirus to delete Pspc1 in 
inguinal WAT. We injected inguinal fat pads of Pspc1fl/fl mice with Ad- 
Cre virus on 1 side and Ad-GFP control virus on the other. All com-
parisons were made between the 2 fat pads within the same animal. 
The efficacy of adenoviral transduction was confirmed by dimin-
ished PSPC1 protein expression in the Ad-Cre–injected fat pads 
(Figure 7, D and E). PSPC1 expression was not altered in the nearby 
quadriceps muscle or in the liver (Supplemental Figure 8D). Adipo-
cyte-specific gene expression was lower in Ad-Cre–injected fat pads 
compared with their Ad-GFP–injected counterparts, including a 
number of the CLIP-identified PSPC1 target genes (Figure 7F). The 
results of Figure 7 indicate that endogenous PSPC1 is indispensable 
for adipose tissue development and maintenance in vivo.
Resistance to diet-induced obesity in adipose-specific Pspc1 knock-
out mice. To address the consequence of chronic loss of PSPC1 in 
mature adipose tissue, we generated adipose tissue–specific Pspc1-
null mice by crossing the floxed mice with adiponectin-Cre trans-
genics. Comparisons were made between littermate homozygous 
Pspc1-floxed mice in the presence or absence of the Cre transgene. 
As expected, mice expressing adiponectin-Cre showed markedly 
reduced Pspc1 mRNA expression in WAT and BAT (Supplemental 
Figure 9A). Adipose PSPC1–deficient mice had body weight com-
parable to that of controls when maintained on chow diet (Figure 
8A). However, when the mice were switched to a high-fat diet 
(60% calories from fat), they gained much less weight (Figure 8A) 
and were visibly leaner (Figure 8B). MRI analysis of body compo-
Figure 9. Adipose-specific PSPC1-deficient mice exhibit increased energy expenditure and glucose tolerance. (A–C) Energy expenditure rate (EE; kcal/kg/h), 
VO2 (ml/kg/h), and VCO2 (ml/kg/h) of Pspc1
fl/fl (F/F) and Pspc1fl/fl Cre+ (KO) mice were analyzed by Columbus Oxymax metabolic chambers after 4 weeks on 
HFD. Twelve-hour light/dark cycles, 72-hour total duration; each light/dark bar represents 12-hour duration. n = 8 per group, female mice. Statistical analysis 
was performed using 2-way ANOVA. (D) Daily food intake normalized to body weight. n = 8 per group, female mice. Comparison was made against F/F control 
mice by Student’s t test. (E) IP glucose tolerance test (GTT) performed on F/F and KO mice after 4 weeks of HFD feeding. n = 5 per group, 14-week-old female 
mice. Comparison at each time point was made against F/F control mice by repeated-measures ANOVA. *P < 0.05, **P < 0.01, ****P < 0.0001. (F) Insulin tol-
erance test (ITT) performed on F/F and KO mice after 10 weeks of HFD feeding. n = 5 per group, 20-week-old female mice. Comparison at each time point was 
made against F/F control mice by repeated-measures ANOVA. (G) Relative gene expression in iWAT from F/F and KO mice after 10 weeks on HFD determined 
by real-time PCR. n = 8 per group, 20-week-old female mice. Comparison was made against F/F control mice by Student’s t test. (H) Relative gene expression 
in iWAT, BAT, and skeletal muscle from F/F and KO mice after 10 weeks on HFD determined by real-time PCR. n = 8 per group, 20-week-old female mice. Com-
parison was made against F/F control mice by Student’s t test. Results are representative of 2 independent cohorts of mice. Error bars represent mean  
+ SEM. *P < 0.05, **P < 0.01.
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splicing, and export (41). Recent studies have highlighted the 
ability of DDX3X to shuttle between nucleus and cytoplasm and 
pointed to a role for DDX3X in RNA nuclear export (45–47). In the 
present study, we demonstrated that PSPC1 interacts with DDX3X 
in adipocytes but not in preadipocytes, and that this is associated 
with the maturation of a subset of adipocyte mRNAs. Knocking 
down DDX3X expression blunted the ability of PSPC1 to increase 
protein levels of its targets, strongly suggesting that DDX3X is an 
important effector of PSPC1’s actions in adipogenesis.
Although DBHS proteins have been characterized as nuclear 
proteins, some evidence points to potential roles for them in the 
cytoplasm. For example, PSPC1, NONO, and SFPQ were isolated 
as part of an RNA-transporting granule in dendrites, suggesting a 
possible function in RNA transport in the cytoplasm. Interestingly, 
DDX3X was also purified from this granule, supporting our finding 
of DDX3X as an interaction partner of PSPC1 (58). Another study 
showed that NONO shuttles to the cytoplasm during cell fusion 
(59). We showed here that PSPC1 traffics from the nucleus to 
the cytoplasm during adipocyte differentiation. Moreover, trans-
location of PSPC1 to the cytoplasm was linked to the increased 
expression of a battery of adipose-specific proteins, including the 
key transcription factor EBF1. These results not only outline a new 
function for PSPC1, but also highlight an additional layer of regu-
latory complexity in the process of adipocyte development.
Reciprocal interactions exist between members of the DBHS 
protein family, and they have been found to form homo- and het-
erodimers in vivo (60). Their interaction raises the question of 
whether PSPC1 acts independently or in a complex with the oth-
er paraspeckle components in adipogenesis. PSPC1 indeed forms 
heterodimers with NONO and SFPQ during adipogenesis, with a 
stronger interaction observed in mature adipocytes than in pread-
ipocytes. Furthermore, we observed translocation of NONO along 
with PSPC1 to the cytoplasm upon adipocyte differentiation, con-
sistent with the possibility that paraspeckle proteins may func-
tion together in promoting mRNA maturation. However, ectopic 
expression of neither NONO nor SFPQ alone was able to facilitate 
adipocyte differentiation, suggesting either that PSPC1 may act 
independently of NONO and SFPQ, or that levels of PSPC1 may 
be limiting during differentiation. The question of whether PSPC1 
acts in concert with NONO and SFPQ or with the noncoding RNA 
NEAT1 in adipocyte development remains to be addressed. Addi-
tional studies will also be required to dissect the precise molecular 
function(s) of PSPC1 in RNA maturation.
To assess how loss of PSPC1 in fat might affect metabolic 
health, we generated preadipocytes and mice lacking Pspc1. Con-
sistent with our in vitro data, we observed impaired adipose tis-
sue development in vivo when preadipocytes expressed a reduced 
amount of PSPC1. Adipose PSPC1–deficient mice did not present 
with lipodystrophy on normal chow diet, indicating that PSPC1 
function is not absolutely required for adipose tissue lipid stor-
age. However, the mice were markedly resistant to high-fat diet–
induced obesity, with diminished mass of both subcutaneous and 
visceral WAT. Histology revealed reduced adipocyte size, similar 
to that observed in heterozygous PPARγ-deficient mice (61). Fur-
thermore, despite their apparent reduced adipose tissue lipid stor-
age capacity, adipose PSPC1–deficient mice did not show expect-
ed systemic consequences of profound lipodystrophy; rather, loss 
(Figure 9H). These data suggest that loss of PSPC1 expression in 
adipose tissue provokes compensatory changes in systemic energy 
balance that offset the impairment in adipose tissue lipid storage. 
In addition, GLUT4 expression levels were elevated in the skeletal 
muscle of adipose PSPC1–deficient mice, potentially contribut-
ing to their improved glucose tolerance (Figure 9H). Collectively, 
our results indicate that the ability of PSPC1 to regulate adipocyte 
mRNA maturation is important for both adipocyte development 
and the function of mature adipose tissue in vivo.
Discussion
Adipogenesis involves different levels of regulation, with the 
majority of known control factors exerting their effects at the 
transcriptional level. In the present study, we delineated a role 
for the RNA-binding protein PSPC1 in adipocyte differentiation. 
PSPC1 is a direct target of PPARγ, and its expression is induced 
during differentiation. Complementary in vitro and in vivo anal-
yses demonstrated that PSPC1 expression facilitates adipocyte- 
specific protein expression and adipogenesis. Deletion of PSPC1 
in mature fat in vivo impairs adipocyte-specific gene expression 
and reduces adipose tissue mass and adipocyte size. Mechanis-
tically, we showed that PSPC1 binds directly to a battery of adi-
pose-specific mRNA transcripts via its 2 RRM domains. PSPC1 
interacts with the RNA export factor DDX3X and translocates 
from the nucleus to the cytoplasm during the course of differentia-
tion, thereby enhancing the nuclear export of its target transcripts. 
Loss of PSPC1 expression in adipose tissue in vivo compromises 
adipocyte development and lipid storage, and affects the develop-
ment of diet-induced obesity and insulin resistance.
Previous work has linked a small number of RNA-binding 
proteins to adipocyte differentiation, most of which appear to be 
involved in RNA splicing. Alternatively spliced isoforms of the 
insulin receptor, lipin, nuclear receptor corepressor 1, and pread-
ipocyte factor 1 (PREF-1) have all been associated with differ-
entiation (49–52). More recently, the alternative-splicing factor 
SAM68 was found to regulate adipogenesis by modulating intron 5 
retention in mTOR transcripts and isoform switching of ribosomal 
S6 kinase (18, 53). RNA-binding motif protein 4 (RBM4) has also 
been reported to regulate the splicing of adipocyte-specific genes, 
including the insulin receptor, PPARγ, and PREF-1, thereby facili-
tating brown adipocyte development (54). Whether other aspects 
of posttranscriptional RNA processing, such as mRNA export from 
the nucleus, mRNA turnover, and translation initiation, are also 
regulated during adipogenesis has heretofore been unclear (55–
57). Furthermore, the importance of RNA processing factors for the 
development and function of adipose tissue in vivo has not been 
tested. Our data identify PSPC1-dependent maturation of adipo-
cyte mRNAs as a new control point in the differentiation process.
In an effort to better understand how paraspeckle complexes 
may contribute to adipogenesis, we purified PSPC1-containing 
complexes. IP–mass spectrometry analysis identified a number of 
adipocyte-specific PSPC1 interaction partners, including DDX3X. 
These findings imply that in specific cellular contexts, the core 
paraspeckle components may recruit different proteins to the 
complex to accomplish tissue-specific functions. DDX3X belongs 
to the DEAD-box RNA helicase family, which has been implicat-
ed in many aspects of RNA metabolism, including transcription, 
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stability studies, differentiated adipocytes were treated with actino-
mycin D (4 μg/ml). RNA samples were collected before and at multiple 
time points after the treatment.
Gene expression analysis. Total RNA was isolated using TRIzol reagent 
(Invitrogen) and reverse transcribed with the iScript cDNA synthesis kit 
(Bio-Rad). cDNA was quantified by real-time PCR using SYBR Green 
Master Mix (Diagenode) on an ABI 7900 instrument. Gene expression 
levels were determined using a standard curve. Each gene was normal-
ized to the housekeeping gene 36B4 and was analyzed in duplicate. 
Primers used for real-time PCR are listed in Supplemental Table 4.
Protein analysis. Whole cell lysate was extracted using RIPA lysis 
buffer (Boston Bioproducts) supplemented with complete protease 
inhibitor cocktail (Roche). Proteins were diluted in NuPAGE loading 
dye (Invitrogen), heated at 95°C for 5 minutes, and run on 4%–12% 
NuPAGE Bis-Tris Gel (Invitrogen). Proteins were transferred to 
Hybond ECL membrane (GE Healthcare) and blotted with PSPC1 
(ab115184, Abcam), PPARγ (81B8, Cell Signaling), EBF1 (ab108369, 
Abcam), SCD1 (sc14719, Santa Cruz Biotechnology), ACSL1 (4047S, 
Cell Signaling), NONO (N8789, Sigma-Aldrich), DDX3X (ab37160, 
Abcam), PPM1B (A300-887A, Bethyl Labs), V5 (R960-25, Invitrogen), 
HMG1 (ab18256, Abcam), actin (A2066, Sigma-Aldrich), and α-tubu-
lin (CP06, Calbiochem) antibodies. Band intensities of scanned blots 
were quantified using ImageJ computer software (NIH).
Chromatin immunoprecipitation. ChIP assays were performed 
according to a standard protocol (30). Briefly, following formaldehyde 
cross-linking, cells were lysed and sonicated using Bioruptor (Diag-
enode) according to the manufacturer’s protocol. Chromatin was 
immunoprecipitated with antibodies against PPARγ (sc7196, Santa 
Cruz Biotechnology) and RXR (sc774, Santa Cruz Biotechnology) over-
night at 4°C in the presence of Protein A/G PLUS agarose beads (Santa 
Cruz Biotechnology). After reversal of cross-linking, DNA was extract-
ed and DNA enrichment was quantified by real-time PCR. Primers 
used were: Pspc1 –0.2 kb forward, TGGAGGAGGGGGTTGTTTTG; 
Pspc1 –0.2 kb reverse, CCGGAGGGTCGAAAGCTAAG; Hbb (hemo-
globin beta) forward, TGGTAGCCTCAGGAGCTTGC; Hbb reverse, 
ATCCAAGATGGGACCAAGCTG. Occupancy was quantified using a 
standard curve and normalized to input DNA.
iCLIP and sequencing. iCLIP assays were performed according 
to a modified protocol (37, 68). Briefly, 10T1/2 cells expressing Flag-
PSPC1 were irradiated with 254 nm UV-C light at 800 mJ/cm2 on ice 
to cross-link proteins to nucleic acids. Upon cell lysis, protein-RNA 
complexes were immunoprecipitated with anti-Flag M2 antibody 
(F1804, Sigma-Aldrich) immobilized on Dynabeads Protein G 
(10003D, Novex) overnight. After high-salt stringent washing, RNAs 
on beads were partially fragmented using micrococcal nuclease 
(M0247S, New England Biolabs), ligated to an RNA adaptor at the 3′ 
end, and radioactively labeled on the 5′ end. Protein-RNA complexes 
were eluted using 3X Flag peptides (F4799, Sigma-Aldrich) and run 
on 4%–12% NuPAGE Bis-Tris Gel (Invitrogen). After transfer to nitro-
cellulose membranes, protein-RNA complexes in the range of 20–40 
kDa above Flag-PSPC1 were recovered and digested with proteinase 
K. Reverse transcription was done with SuperScript III Reverse Tran-
scriptase (18080044, Invitrogen), using primers containing 2 inverse-
ly oriented adaptor regions separated by a BamHI site as well as a 
3-nt barcode to mark individual cDNA molecules. cDNAs were size- 
purified using denaturing gel electrophoresis, circularized by CircLi-
gase II ssDNA ligase (CL9021K, Epicentre), and linearized by FastDi-
of adipose PSPC1 in a high-fat diet–fed state resulted in improved 
glucose tolerance and insulin sensitivity.
Previous studies have found that impairment of mature adi-
pocyte function, including alterations in lipogenesis and lipoly-
sis, can provoke compensatory responses in other metabolic tis-
sues (62, 63). For example, such compensatory effects have been 
observed with Pparg hypomorphic mice. Despite being lipodystro-
phic, these mice exhibit relatively benign metabolic consequenc-
es due to induction of a gene expression program in muscle that 
enables efficient oxidation of excess lipids (64). A second adi-
pose-specific aP2-Cre–driven Pparg knockout model also demon-
strated improved glucose tolerance on high-fat diet, possibly due 
to a compensatory increase in hepatic glucose disposal (65). Con-
sistent with these findings, we observed that loss of PSPC1 expres-
sion in fat led to an increase in genes linked to thermogenesis in 
BAT and fatty acid utilization in skeletal muscle. Increased expres-
sion of skeletal muscle GLUT4 further suggests that enhanced 
muscle glucose uptake is likely to contribute to improved glucose 
tolerance and insulin sensitivity.
Methods
Reagents and plasmids. Dexamethasone (D2915), 3-isobutyl-1-meth-
ylxanthine (IBMX, I7018), PPARγ agonist GW1929 (G5668), and 
actinomycin D (A1410) were from Sigma-Aldrich. Insulin (12585-
014) was from Gibco. PSPC1 shRNA sequences were designed using 
BLOCK-iT RNAi designer tool (Invitrogen). Sense and antisense 
oligos were annealed and cloned into pENTR/U6 plasmid (Invitro-
gen). Using LR recombination (Invitrogen), shRNA constructs were 
subcloned into a Gateway-adapted pBabe-Puro plasmid. The follow-
ing shRNA oligos were used: lacZ shRNA, CACCGGGCCAGCTG-
TATAGACATCTCGAAAGATGTCTATACAGCTGGCCC; PSPC1 
shRNA1, CACCGGTTGTTTCCAATGAGCTTCTCGAAAGAAGCT-
CATTGGAAACAACC; PSPC1 shRNA2, CACCGCGGCTTTAAAC-
CAAACTATACGAATATAGTTTGGTTTAAAGCCGC; and PSPC1 
shRNA3, CACCGCAAATATGGGAACTCCAATGCGAACATTG-
GAGTTCCCATATTTGC. Only sense strands are shown here. 
ON-TARGETplus mouse DDX3X siRNA SMARTpool (L-043597) and 
Non-targeting Pool (D-001810) were from Dharmacon. Adenovirus 
was amplified, purified, and titered by Viraquest Inc.
Cell culture. 3T3-L1, 3T3-F442A, and NIH-3T3 cells were obtained 
from ATCC and cultured in DMEM supplemented with 10% bovine 
calf serum. 10T1/2 preadipocytes and murine brown preadipocytes 
were cultured in DMEM with 10% FBS. For white adipocyte differen-
tiation, preadipocytes were grown to confluence in DMEM with 10% 
FBS plus insulin (5 μg/ml). Confluent cells were induced to differen-
tiate with dexamethasone (1 μM), IBMX (0.5 mM), insulin (5 μg/ml), 
and GW1929 for 2 days, followed by insulin and GW1929 alone. For 
brown adipocyte differentiation, cells were plated in DMEM contain-
ing 10% FBS plus insulin (5 μg/ml) and T3 (1 nM). After confluence, 
cells were stimulated to differentiate with dexamethasone (5 μM), 
IBMX (0.5 mM), indomethacin (125 μM), insulin (5 μg/ml), T3 (1 nM), 
and GW1929 for 2 days, followed by insulin (5 μg/ml), T3 (1 nM), 
and GW1929. Growth medium was exchanged every 2 days during 
the course of differentiation. Brown preadipocytes were isolated and 
immortalized as described (66). All stable cells were generated using 
the pBabe retroviral system (67). Preadipocytes were transduced with 
retrovirus overnight and selected with particular antibiotics. For RNA 
Downloaded from http://www.jci.org on December 15, 2017.   https://doi.org/10.1172/JCI89484
The Journal of Clinical Investigation R E S E A R C H  A R T I C L E
1 0 0 2 jci.org   Volume 127   Number 3   March 2017
PBS for 30 minutes. Cells were incubated with V5 (R960-25, Invi-
trogen) or Psps1 (sc374181, Santa Cruz Biotechnology) antibody in 
blocking buffer overnight at 4°C. After washes, cells were incubat-
ed with Alexa Fluor 594–conjugated secondary antibody (A-21125, 
Invitrogen) for 1 hour at room temperature and washed. Cells were 
stained with BODIPY 493/503 (Invitrogen) and/or DAPI (Invitro-
gen). Cells were visualized with an LSM510 confocal laser scan-
ning microscope (Carl Zeiss).
Pspc1 adipose-specific knockout mice. A conditional-potential 
knockout allele for Pspc1 was generated using a “targeted trapping/
conditional-ready” gene-targeting vector (Pspc1tm1a) (Supplemental 
Figure 8B). The targeting vector was electroporated into C57BL/6N 
ES cell line JM8.N4. Out of 12 validated targeted ES cell clones, a 
euploid clone (clone A11) was selected for in vitro Flp recombination. 
Flp recombinase excised the gene-trapping cassette within intron 1 of 
Pspc1, producing a conditional knockout allele containing a loxP site 
in intron 1 and a loxP site in intron 2. Genotyping was completed by 
amplification of the genomic region flanking loxP sites using the fol-
lowing primer pairs: forward ACGTAGCCCAGGTAGGTATTTCAGG 
and reverse TGTAACAAGATCTGATGTCCTCTTCTGG (Supple-
mental Figure 8C). Eleven clones passed Flp testing, and clone A11_
flp_A09 was selected and injected into BALB/c blastocysts to generate 
chimeric mice. High-percentage male chimeras were obtained, and 
were crossed to C57BL/6N mice to establish germline transmission. 
Homozygous Pspc1-floxed mice were crossed with adiponectin-Cre 
mice (a gift of Evan Rosen, Beth Israel Hospital, Boston, Massachu-
setts, USA) to generate adipose-specific PSPC1-deficient mice.
Animal studies. For the preadipocyte transplantation study, 
6-week-old male NCr nude mice were acquired from Taconic. Mice 
were anesthetized using 2%–3% isoflurane in O2. Using an insulin 
syringe attached to a 28-gauge needle, 2 × 107 3T3-F442A preadipo-
cytes were injected subcutaneously over the sternum. Newly formed 
subcutaneous fat pads were dissected, weighed, and processed for his-
tological and gene expression analysis. Homozygous Pspc1-floxed mice 
carrying the conditional-ready knockout allele were used for adenovi-
rus-Cre injection studies. For the adenovirus delivery to fat pads, 2 × 
109 PFU of adenovirus was percutaneously injected into the inguinal 
fat depot at 8 weeks of age (71). In each mouse, Ad-Cre was injected 
on one side, and Ad-GFP was injected on the contralateral side. Seven 
days after the injection, iWAT was resected for analysis. At 10 weeks 
of age, Pspc1fl/fl Cre+ mice and their Pspc1fl/fl littermates were fed a 60% 
high-fat diet (Research Diets) for the indicated times. For glucose tol-
erance tests, mice were fasted for 6 hours and challenged with an i.p. 
injection of glucose (2 g/kg). For insulin tolerance tests, mice were 
fasted for 6 hours and given an i.p. injection of insulin (1 U/kg). Blood 
glucose levels were monitored using the Accu-Chek active glucome-
ter (Roche). Body composition was determined by EchoMRI analysis. 
Indirect calorimetry was performed using a Columbus Instruments 
Comprehensive Lab Animal Monitoring System. Animals were placed 
individually in chambers for 3 consecutive days at ambient tempera-
ture (26.5°C) with 12-hour light/dark cycles. Respiratory measure-
ments were made in 20-minute intervals after an initial 7- to 9-hour 
acclimation period. Energy expenditure rate (EE) was calculated from 
VO2 and respiratory exchange ratio (RER) using the Lusk equation, 
EE in kcal/kg/h = (3.815 + 1.232 × RER) × VO2 in ml/kg/h. Statistical 
significance for EE, VO2, and VCO2 measurements was determined by 
2-way ANOVA. Analysis of EE with body mass or lean mass as covari-
gest BamHI (FD0054, Thermo Fisher Scientific). Linearized cDNAs 
were PCR-amplified and subjected to high-throughput sequencing 
(single end 100 nt) using Illumina HiSeq2000.
iCLIP-Seq data analysis. CLIP-Seq reads were trimmed to remove 
adaptor sequences and categorized according to different barcodes. To 
eliminate redundancies created by PCR duplicates, all reads with iden-
tical adaptor sequence were considered a single read. Quality control 
check was applied to all the trimmed reads using the FastQC tool from 
Babraham Bioinformatics. CLIP-Seq reads of at least 12 nt in length 
were mapped to the mouse genome (NCBI37/mm9) using the TopHat 
alignment pipeline on UCLA Galaxy platform with parameters set to 
search for unique alignment, with fewer than 2 mismatches, and with 
no indels. Mapped reads were then subjected to the CLIP-Seq clus-
ter-finding algorithm CLIPper to call significant (FDR < 0.05, P < 0.05) 
clusters (39). Significant clusters were uploaded onto the University of 
California, Santa Cruz, Genome Browser as custom annotation tracks. 
Read distribution over the genome was analyzed using the RSeQC tool 
(69). De novo motif search was performed using the HOMER findMo-
tifsGenome program with parameters -rna -S 10 -len 4,5,6 -size given 
-h -nlen 0 -noweight. Background sequences were from CLIP-Seq reads 
of the experimental control library (40).
Co-IP and mass spectrometry. Cells expressing Flag-PSPC1 were 
lysed with ice-cold lysis buffer containing 50 mM Tris-HCl pH 7.5, 
150 mM NaCl, 0.6% Triton X-100, plus complete protease inhibitor 
(Roche). Cell lysates were precleared with empty Protein A/G PLUS 
agarose beads (Santa Cruz Biotechnology) and then immunoprecipi-
tated with beads prelinked with anti-Flag M2 antibody (F1804, Sigma- 
Aldrich) overnight at 4°C. Beads were washed with 50 mM Tris-HCl 
pH 7.5, 150 mM NaCl, and 0.1% Triton X-100, then eluted with 3X 
Flag peptides (F4799, Sigma-Aldrich). In specific experiments, RNase 
(AM2286, Ambion) was used to treat cell lysates before IP. IP eluents 
from Flag-PSPC1 cells and control cells were processed by nano– 
liquid chromatography with data-dependent tandem mass spectrom-
etry performed on an Orbitrap mass spectrometer (70). The results 
were analyzed using Mascot software (Matrix Sciences).
Subcellular fractionation. Cells were washed with 1× PBS and incu-
bated with TEN buffer (10 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM 
EDTA pH 8.0). Cells were allowed to swell on ice for 15 minutes in 10 
mM HEPES, 10 mM KCl, 0.1 mM EGTA, 0.1 mM EDTA, 1 mM DTT, 
plus complete protease inhibitor (Roche). Cells were then mixed with 
NP-40 alternative (Calbiochem) to a final concentration of 0.4%, 
incubated for 5 minutes, and centrifuged at 12,000 g for 5 minutes. 
Supernatant was collected as the cytoplasmic fraction. Nuclear pellet 
was resuspended in 20 mM HEPES, 420 mM NaCl, 1.5 mM MgCl2, 
0.2 mM EDTA, 25% glycerol, 1 mM DTT, plus complete protease 
inhibitor. After a 15-minute incubation, nuclear extracts were spun at 
12,000 g for 5 minutes, and the supernatant was saved for future anal-
ysis. For RNA analysis, all the buffers above were supplemented with 
10 mM ribonucleoside-vanadyl complex (New England Biolabs) to 
inhibit ribonucleases. RNA was extracted from the nuclear and cyto-
plasmic fraction using a Purelink kit (Ambion).
Immunofluorescence. 10T1/2 cells were plated in gelatin-coated 
glass-bottom dishes (MatTek). At day 0 and day 6 of differentia-
tion, cells were fixed with 4% paraformaldehyde in PBS. Cells were 
permeabilized with 0.1% Triton and treated with NH4Cl to quench 
free aldehyde groups. Cells were then blocked with 5% normal 
goat serum (Vector Laboratories) and 1% BSA (Sigma-Aldrich) in 
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